Early Rheumatoid Arthritis Clinical Trial
Official title:
Power Doppler in Hand Joints is a Predictor of Therapeutic Failure in Women With Early Rheumatoid Arthritis Naive for Treatment
It is a prospective case-control study with women diagnosed early rheumatoid arthritis. Three therapeutic failures were considered: failure 1 - to the first Disease-modifying antirheumatic drugs (DMARDs) (methotrexate); failure 2 - to the second DMARDs (leflunomide) and failure 3 - to the first immunobiological drugs (adalimumab). Ultrasound was performed bilaterally on the 2nd and 3rd metacarpophalangeal joints (MCFs), proximal interphalangeal joints (IFPs), and wrists (US10). Ultrasound measurements (qualitative and semi-quantitative) evaluated: 1 - inflammatory: synovial and tenosynovial proliferation in gray scale and power Doppler (0-3); 2 - joint damage: bone erosion (qualitative and semi-quantitative) and cartilage damage (qualitative and semi-quantitative). Clinical and laboratory variables were also assessed blindly at baseline and after 12, 24 e 48 weeks.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01768923 -
Early RA Vascular Randomised Controlled Study
|
N/A | |
| Completed |
NCT01762176 -
Early RA MRI Early Intensive Treatment Study
|
N/A | |
| Completed |
NCT01185301 -
Study to Determine the Effects of Different Doses of Methotrexate (MTX) When Taken With Adalimumab in Subjects With Early Rheumatoid Arthritis (RA)
|
Phase 3 | |
| Recruiting |
NCT03755258 -
Trial of Ginsenoside Compound K (GCK) Tablet in Patients With Rheumatoid Arthritis
|
Phase 1 | |
| Recruiting |
NCT03389711 -
INCMNSZ - Rheumatoid Arthritis Cohort
|
||
| Completed |
NCT00195663 -
Efficacy and Safety of Adalimumab and Methotrexate (MTX) Versus MTX Monotherapy in Subjects With Early Rheumatoid Arthritis
|
Phase 3 |